Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer
Status:
Completed
Trial end date:
2015-12-15
Target enrollment:
Participant gender:
Summary
RATIONALE: Androgens can cause the growth of prostate cancer cells. Drugs, such as goserelin,
may stop the adrenal glands from making androgens. Drugs used in chemotherapy, such as
docetaxel, work in different ways to stop the growth of tumor cells, either by killing the
cells or by stopping them from dividing. Giving hormone therapy together with docetaxel may
be an effective treatment for prostate cancer. It is not yet known whether giving hormone
therapy together with docetaxel is more effective than hormone therapy alone in treating
prostate cancer.
PURPOSE: This randomized phase III trial is studying hormone therapy and docetaxel to see how
well they work compared to hormone therapy alone in treating patients with metastatic
prostate cancer.